Cancer Lifeline
Company Limited by Guarantse
Statement of Financial Activities
(including income and expenditure account)
Year ended 31 March 2025
2025
UnrestrirteA Restricted
funds
fijnds Totsl fund$ Total funds
2024
Noto
Income and endowments
Donations and kgacies
Charitable activities
Other trading actiVit￿S
Other income
112,616
112,616
334,348
49,325
5.512
68,315
386.195
70.091
5,803
530.404
334.348
49,325
5.512
Total Income
167.453
334.348
501,801
Expendlture
Expenditure on raising fvnds..
Costs of other trading activitses
Expendrture on Charitab￿ actNibes
Totsl expenditure
72.144
118.741
72.144
461,134
533,278
114,691
458.053
10,11
342.393
342.393
19J,885
572.744
Net expendtture and net movement In
funds
(23.4321
(8,045)
(31,4771
142,3401
Reconciliation of funds
Totsl fvnds brought foTrvard as prvrftousPy
reported
Prior year adjustment
Total funds brought forward as restated
Total funds carrled fonvanl
510.510
857,980 1.368,49)
560,830
8SO,000
1.410,830
510.510
857,980
849,935
1.368,4
1.337.013
487,078
1,368,490
The statement of firlancial actNities includes all gains and losses rewgnised in the year.
All income and expenditure derive from continuing ￿plItIes.
Th• not•5 on pays 22 to 36 forni wt of th¢8• fmanelal statemgnts.
19

Cancer Lifeline
Company Llmlted by Guarantee
Statement of Financial Position
31 March 2025
2025
2024
(r•&41odJ
No*
Fixed assets
Tangible fixed assets
17 1.034,064
1,052,550
Current assets
Debtors
Cash al bank and in hand
18
5.383
312.822
5,443
372,207
318.205
377,650
Creditors: amounts falling due wlthln one year
Net current assets
20
15,256
302,949
1,337.013
1.337.013
61,710
315.940
Total assets Jess current Ilabllllles
1,368,490
1.368,490
Net assets
Funds of the charlty
Restricted funds
Unrestricted funds
849,935
487,078
857,980
510,510
Total charity funds
1,337.013
1.368,490
These financial statemetts have been prepared Mi accordance with th8 promsions applicable lo
ccwnpanies subject to the small companies, regime.
These financial statsm&tts were approved by the lThrd of trustees and autt)orised for tssue on 22
September 2025. and are signed ￿ behalf of the board by:
R McGuvJan
Trustee
B Montg
Trustee
T￿ not•s on pages 22 to 36forni part olth•s• fin¥nciil $tat•Thents.

Cancer Lifeline
Company Limited by Guarantee
Statement of Cash Flows
Year ended 31 March 2025
2025
2024
(r•51at•dJ
Cash flows from operatlng actlvitles
Net expendrture
131.477)
142.340)
Adjustments for.
Depreciation of tangible f￿ed assets
Interest payable and similar charges
Gains on disposal of tsngible fixed assets
Accrued (incomellexpen5es
26.948
1,842
13.9C6}
{4.050>
12,031
1,848
8,520
Changes in..
Trade and other debtors
Trade and ot￿r Cr￿itOrS
(4.5431
22.620
(19,421)
(30,CrfJ4)
Cash generated from operations
(1.8641
Interest paid
Nel cash used in cyerating activities
{1.842)
(31.846)
11.848)
{3.712)
Cash flows from investing activities
Purchase of tangible assets
Proceeds from sale ofLqngible assets
Net cash used in investin9 actNilies
(11,556) (850,OCh)I
(8.462) (850.000)
Net decrease In cash and cash equivalents
Cash and cash equlvalents at beglnnlng of year
Cash and cash equivalents at end of year
(40,308) (853.712)
346.678
350,390
(503,3221
19
306.370
Th• nots8 on pag•s 22 to 36 fomi p•rt of thMo financial 8tat•mont*.
21

Cancer Lifeline
Company Limited by Guarantee
Notes to the Financial Statements
Year ended 31 March 2025
Generdl infonnation
The charity is a public benefft entty arKI a private company limited by guarantee. registered in
Northern Ireland and a registered tharity in Northem Ireland. address of the registered office
is 44 Alliance Avenue, Belfast. BT14 7PJ.
Statsment of compliance
These financial statements have been prepared in compliance with FRS 102, The Financial
Reporting Standard applicable in the UK and the Republic of Ireland, the Statement of
Recomrneftded Practice applicable to chafities Preparing their accounts in accordance wilh the
Financial Reporting Standard appluble in the UK and Republic of Ireland (FRS 1021 {Charities
SORP (FRS 102}) and the Companie5 Act 2006.
Accounllng polkles
Basis of preparation
The financi￿ Statements have been prepared on the historicat cost basis, a5 Modif￿ by the
revduation of certain financial assets and li8bilities aThJ investment properties measured at fair
value through income or expenditure.
The financial statements are prepared in sterting. which is the functional currency of the entity.
Going concern
There are no material uncertainties abcAJt the ch&iV5 abilty to continue.
Judgements and key sources of estirnation uncertainty
The preparation of the financial stateAnents requires management to rnake judgements.
estimates and assumptions that affect the amounts repjrted. These estim*es and judgements
are continualfy reviewed and are based on experience and other fa¢lors, including expectat￿)n8
of future events that are believed to be reasonable under the circumstances.
Fund accountlng
Unrestricted funds are available ts use a the dIscret￿n of the trustees to further ary of the
¢harty's purposes.
Designated funds are unrestricted funds eam*rked by the trusW for particular future prcyect or
commthent.
Restri¢*d funds are subj'ected to restrictK)rts on their expenditure d￿lared by the donor or
through the temis of an appeal. and fall into cfft of two SU￿laSses. wlrricted income funds or
endowment funds.

Cancer Lifeline
Company Llmited by Guarantee
Notes to the Financial Statements (conlinue
Year ended 31 March 2025
Accounting policies (conllnuod)
Inc¢)ming r8sourc•s
All incoming resources are induded in the Statement of financial activrties when entitlement has
passed lo the charity" it is probab￿ that the economic benefits associated with the transaction
will ftow to the charty and the amount can be rel&)ly measured. The following sp￿lf￿ policies
are applied to particular categories of incorne..
income from donatK*ns or grants i8 ￿c03n[sed when there is evidence cl entitlement to Ihe
grft, receipt is probable and rts amount can be measured reliably.
legacy income i8 rects3nised when r￿lpt is probable and errtitlement is established
inGome from donated goods is measured at the fair value of the goods unless this is
impractical to measure reliabty. in which case the value is derived from the cost to the donor
or the estimated ￿$•￿e value. Donated facilities and Ser￿e$ are recDJnised in the
accounts when rtteived if the value can be reliabty measured. No amounts are included for
the ¢ontribulion of general volunteers.
income from contracts for th8 suppty of services is reco3nised wrth the delwery of the
contracted service. This ts classffied as unrestricted funds unless there is a contractual
requirement for it to be sFenl on a parti(yJlar purpose and retumed rf unspen( in which case
it may be regarded as restricted.
Resources •xpendfjd
Expenditure is recognised on an accruats basis as a liability is incurred. Expenditure includes any
VAT whtch cannot be fully recovered. and is dassrfied under headings of the statement of
financial actNtties to which it reL3tes:
expenditure on raising funds includes the costs c4 all fundraisrng actiVit￿S. ￿ents.
non<haritable trading actNities. and the sale of don*ed g￿lds.
expendtture on charitable *ivities ￿dUdeS ￿1 costs Incur￿ by a charity in undertaking
activities that further its charitable aims for the benefit of Tts benef￿lanes, induding thos&
support costs and costs relating to the govemance of the charity apporttoned to charitable
activities.
other expenditure inC￿deS all expenditure that 1$ rnitt)er rel*ed to raising funds for the
charity part of its expenditure ￿ charrtable activities.
All costs are allLxaled to expendrture categortes relleGting the use of the resource. Dir￿1 costs
attributable to a single activty a￿ all￿at￿ directty to thal actwity. Shared costs are apportioned
betsveen the acltvtties they contribute to on a reasonable. justifiable and consistent basis.
Tangible as8ets
Tangible assets are inibalty recorded at cost. and subsequently staled at cost less any
accumulated depreciation and impaimient b)sses. Any tangib￿ assets carried at revalued
amounts are recorded at the fair value at the date of revauatron less any subsequent
acwmulaed depr￿aknn and subsequent ￿NnU1*ed Iwirnenl losses.

Cancer Lifeline
Company Limited by Guarantee
Notes to the Financial Ststements (eonfrn
Year ended 31 March 2025
Accounting policies (conlinw¢
Tangiblè assots
An increase in the carrying amount of an asset as a result of a revaluation, is recognk8ed in other
reccgnised gains and losses, un￿sS it reverses a charge for impawment that has previously been
ognised as expenditure within the statement of financial aclivities. A decrease in the Carrying
amount of an asset as a resutt of T￿￿UatiOn, is re￿nised in other recognised gains and losses.
except to which il offsets any prevk)us revaluatton gain. in which case the kjss is shvhn_wilhin
other recognised gains and losses on the statem￿1 of financial activities.
Dopreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, ￿sS its r85idual
value, over the Usef￿ economtc lrfe of th* asset as folkyws:
Long leasehold pr<Jperty
Motor vehicles
Equipment
2'h straight line
25% reducing balar￿8
2(Yk reducin9 balance
Impalrnient of fixed assets
A wew for Indicato￿ of impaimwnt is carr￿d out at each reporbng date, wlth the recoverable
amount being estimated where SLKh indicators exist. Where the carrying value exceeds the
coverable amount. the asset is impaired accordirKJty. Prtor impairments are also reVI￿d for
possible reversal at each reportuig date.
For the purposes of Impalm￿nt testiThJ. when it is not wssble to estinate the recoverable
nount of an indivrdual asset. an eslirnate is made of the recoverable amount of the
c2sh-generating unil to which the assel belongs. The cash-generabn9 untt is the smallest
identifiable group of assets thal indudes the assel and gener*es cash infiows that largely
independent ol the infltrws from other assets or groups of assets.
For Impalm￿l￿ testing of 9oodwill. the g¢W)d*￿Il wuired in a business ccrtjination is. the
acquisition date. aliocated to e&h of the cash-generating units that are expected to benefrt from
the synergies of the combination. irrespective of whether other assets or liabilities of the charity
are assign￿ to those unrts.

Cancer Lifeline
Company Limited by Guarantee
Notes to the Financial Statements l¢onl•l￿d}
Year ended 31 March 2025
Accounting policies (C¢￿1)￿￿
Financial Instruments
A financial asset or a financial liabilty is recognised only when the charity bec(￿￿ a party to the
contractual provisK)ns of the inslrumenL
Basic financial instruments are initialty rwni%ed at the amount receivable or payable including
any reLgted transaction costs.
Current assets and current liabilities we subsequentty measured at the cash or other
Consideration expected to be patd or recerved and not d￿ounted.
Debt instruments are subsequentty measured at amortised cosL
Where investrnents in shares are publicty tr*Yed ty their fair value can otherwise be measured
reliably, the investment is subsequentty measured at fair value with changes in fair value
recc4Jnised in income and expenditure. All other such investments are subsequently measured at
cost less impairmenL
Other financial instruments. i￿lUding derivalrves, are initsauy rwnised at fair value. unths
payment for an asset is deferrgj beyond nomal business tems or financed * a rale of interest
that is not a market rate, in wh￿h case the asset is measured at the present value of the future
payments discounted at a market rate of interest for a simikr debt instrument.
Other financtal instruments a￿ subsequenty ￿eaSured at fair value, wtth any changes
recagnised in Ihe statement of financial actpiities. with the ex¢epth)n of hedging instruments in
designated hedging relationship.
Financial assets that are measured al cost or arnort￿d cost a￿ reviewed for objective
evidence of impairment at the end of exh rewrting dale. If there is objective evidence of
impaimient. an impaimient loss is recc¥3nised under the approprgte heading in the statement of
financial activitie$ in which the inrb.al gain was rec(>3nised.
For all equty instruments regardless of signrficance, and other financial assets that are
individually significanl, Ihese are assessed individually for impaimient. Other financial assets are
either assessed individually or wuped on the basis cl similar credlt rtsk characteristics.
Any reversals of impaimient are recognised immthliately, to extent tha the reversa do8s not
resu￿ in a carrying amount of the financial asset that exceeds what the carrying amount would
have been had the irrpairnRnt not prevK)usty been recognksgj.
Defined contribution plans
Contributs'ons to defined contributK)n plans are recognised as an expense in the period in which
the related SeThI￿ is kyovided. Prepaid contributions are recognised as an asset to the extent
that the prepayTnent will lead to a redUct￿n in future payments or a cash refund.

Cancer Lifeline
Company Limited by Guarantee
Notes to the Financial Statsments {c¢7nthu8dJ
Year ended 31 March 2025
Accountlng policies (¢ontlnL
Defined contrlbutlon plans (eonthu•dJ
en contributions are not expected to be sett￿d wholty within 12 months of the end of the
reporting date in which the employees render the related ser¥￿e, the liabilty is measured on a
discounted present value basis. The unwinding of the discount is recognised as an expense in
the period in whKh it arises.
Limited by guarantee
The charity is a public benefft entty and 8 private company limited by guarantee. registered in
Northern Ireland and a registered charty in Northern Irdand. The address of the registered office
is 44 Aliance Avenue, Belfast, BT14 7PJ.
Donations and legacies
Unrestricted Totsl Funds UnrestricteA Tcrtal Funds
Funds
2025
Funds
2024
Donations
Donations
Collection boxes
108.458
4,158
112.616
108,458
4.158
63,948
4,367
68.315
4,367
112,616
68.315
Charltable activities
Restricted Total Funds Restricted T(rtal Funds
Funds
2025
Funds
2024
{Kest•tedJ
DFC (Neighbourhood Renewal)
The National Lottery Community Fund
(People in Communities Prcsramme)
HSC (Public Health Agency)
BHSCT {Careffs Support SeN¢esl
BHSCT {Primary Care Tall(ing
Therapies)
Belfast Cty Council (Revenue Gr￿rt}
CFNI (through the Department of
Health Cancer Charity Support Fund)
The National Lottery Community Fund
(through Dom)ant A¢counts Nl)
PHA
Halrfax
DomiantA¢courtts
CFNI
83,134
83.134
37,421
37.421
50.254
93,520
11.124
50,254
93.520
11,124
13,114
13.114
3.266
49,981
20,629
20.629
49.981
24.512
24,512
73.565
73.565
26.537
26.537
110.774
110.774
9.900
27.012
27,012
7,852
7.852
334.348 334.348 386,195
386.195

Cancer Lifeline
Company Limited by Guarantse
Notes to the Financial Ststements (conlinwd)
Year ended 31 Pljarch 2025
Other trdding actlvltles
Unrestricted Total Funds Unrestricted Total Funds
Funts
2025
Funds
2024
Shop income
49,325
49.325
70,091
70,091
Other Income
Unre5tricled Total Funds Unrestricted T￿4 Funds
Fund5
2025
Fund5
2024
Gain on disposal of tsngible fixed
assets held for ¢harity's ovm use
Sundry income
3.906
1.606
3.906
5.803
5,803
5.512
5.512
5,803
5,803
Costs of other trading activitk8
Unrestricted Totsl Funts Unrestricted Tclal Funds
Funds
2025
Funds
2024
(rest•leoJ
Costs of other trading aCt￿￿e$- Shop
costs
72.144
72.144
114.691
114,691
10. Expenditure on charitable activities by fund type
Unrestricted Resthcted Totsl Funds
Funds
Funds
2025
Charitable activity
Support costs
118.741
255,019
87.374
373.760
87.374
118.741
342,393
461,134
Unrestl￿ted Restricted Tota] Funds
Funts
Funds
2024
(reststed)
Charitable activty
Support costs
36,448
15.631
354,030
51.944
390.478
67,575
52.079
405,974
458,053

Cancer Lifeline
Company Llmited by Guarantee
Notes to the Financial Ststsments {c¢xJtinu8
Year ended 31 March 2025
11. Expendituro on charilable activtties by actNty type
Actr4ities
undertaken
directty Supp(rt costs
Total funds
2025
Total fund
2024
Charitable activity
Governance costs
373,760
76.404
10.970
450,164
10,970
461,134
444,713
13,340
458,053
373.7EA)
87.374
12. Analysls of support costs
Analysis of
support costs Total 2025 Total 2024
P￿miseS
G￿lmunICatiOnS and IT
General office
Finance costs
Goveman¢e Costs
31,475
4.234
38.853
1,842
10,970
87,374
31.475
4,234
38.853
1.842
10,970
87.374
11.059
5,307
36.021
1,848
13.340
67,575
13. Net expenditure
Net expenditure is stated after chargingl{crediti'ng):
2025
2024
(restsied)
Depwiation of tangible frAed assets
Gain$ on disposal of tangible f￿ed assets
26,948
13,906}
12.031
1& Auditors remunerdtion
2025
2024
Fees payable for the audit of the ffinancial statements
4,470
4.260

Cancer Lifeline
Company Limited by Guarantee
Notes to the Financial Ststemonts (contin￿0?
Year ended 31 March 2025
IS. Staff costs
The total staff costs and er￿jE0Yee benefits for the reporbng perirA are anatysed as follows..
2025
2024
{restaled)
Wages and salaries
Social security costs
Empbyer contributions lo PenS￿n ￿anS
22S.142
14,241
21.787
235,757
18.814
20,424
274.995
261.170
The average he&J Count of ernpbY￿ during the year V•BS 12 {2024: 12).
No employee receNed employee benefrts of more than £60.IX)O during Ihe year12024: Nil).
Key Management Pernonnol
Key management personnel ind￿je all persons that have authority and responsibility for
planning. directing and contrdling the activities of the ¢hanty. The total compensation paid to key
management personnel for services provided to the chanty vras £106.530 {2024.'£106.267).
16. Trust8e remuneration and expenses
No Trustee received emoluments during the year (2024:Nil)
The Trustees, received in total £1.060 (2024'.£2.172) in re1Mbu￿ernent of expenses. The
reimbursement is made for c05t of travelling on Charrty business in retation to th￿r duties a5
Trustees, and also las with other volunteers) the reimbutsement of costs incurred during support
visitatrons.

Cancer Lifeline
Company Limited by Guarantee
Notes to the Financial Statements (el￿1¥1￿•￿)
Year ended 31 Paarch 2025
17. Tangible fixod assets
Long
sehold
property
Motor
vehicles
Equipment
Total
Cost
At 1 April 2024 (as restated)
Addibons
Disposals
At 31 March 2025
1.143.983
11,5
11.000
129,380
1,284.363
11.556
111,000)
1.284,919
(11,LlJO)
1.155.539
129.380
Depreciation
Al 1 April 2024
Charge for the year
Disposals
At 31 March 2025
109,87T
23,111
114.030
3,837
231,813
26,948
(7.906)
250.855
17.gJ6)
132.988
117.867
Carrylng amount
At 31 March 2025
1.022.551
1.034,106
11.513
15.350
1.034.
1.052,550
At 31 March 2024
1& Debtors
2025
2024
(Mt•rtedJ
Trade debtors
Prepayments and accrued income
Other debtors
900
3,324
1,219
4.196
1.187
5.383
5,443
19. Cash and cash equivalents
Cash and cash equivalents c(ryrise the f01b￿lng.
2024
Cash at bank and in hand
Bank overdrafts
312.822
(2.546)
310.276
372.207
(25.529)
346.678

Cancer Lifeline
Company Limited by Guarantee
Notes to the Flnancial Statements l¢Mlty•wo)
Year ended 31 March 2025
20. CredStors: amounts falling due within one year
2025
2024
(reststed)
Bank loans and overdrafts
Trade creditors
AccTuals and deferred income
Social security and other taxes
25.529
2,778
33.032
371
2.060
10.650
15.256
61.710
21. D￿erred income
2025
2024
(r•staiedJ
At 1 April 2024
Amount released to income
Amount deferred in year
At 31 March 2025
24.512
{24.512)
6,180
6.180
24.512
24,512
22. Penslons and other post rellrement beneffts
Defined contributlon plans
The amount recognised irb income or expenditu￿ as an expense in relation to defined
contribution plans was £21.787 (2024. £20.424).
31

Cancer Lifeline
Company Llmlted by Guarantee
Notes to the Financial Statements l¢ontinu•d)
Year ended 31 March 2025
23. Anatysis of charitable funds
UnroStrict8d fund8
At
1 Apr 2024
Prior year
At
Transfers adjustments 31 Mar 2025
Income Expenditure
General Funds
General funds-
property fund
DeS￿nated Fund
62.142
167,453
1190,885)
38,710
161,9
286,372
510.510
161.9
286.372
167.453 (190.885)
487.078
At
1 Apr 2023
Prior year
At
Transfers &Jjustsnents 31 Mar 2024
Income Expenditure
General Funds
General funds-
propety fund
Designated Fund
146.422
144,209 (166.770) (61.719)
62.142
161.996
62,508
161,9
286,372
223,864
370,286
144.209 (166.770)
162.785
510,510
32

Cancer Lifeline
Company Limited by Guarantee
Notes to the Financial Statements (¢onthu•d)
Year ended 31 March 2025
23. Analy$ls of Charilable funds (co•thu8d)
Restrlcted funds
At
1 Apr 2024
Prior year
At
Income Expendf(ure Transfers adjustments 31 Mar 2025
Reslricled Funds
- operating fund
Restricted-
Propety Fund
DFC
(Neighbcurhocal
Renewal)
National Lottery
Communty Fund
(People in
Communilies)
HSC (PUb￿C
Health Agency)
BHSCT {Care¢s
support service)
BHSCT (Primary
care talking
therapies)
Belfast City
Council (Revenue
Grant)
CFNI (thrcugh
DOH Carers
grant)
CFNI (through
DOH Can¢er
Charity Support
Fund)
National Lottery
Communty Fund
IDom)ant
Accounts)
PHA
Domiant
Accounts
CFNI
Bdfast City
Counal - Property
83,134
{83.134)
37.421
(32.319)
5,102
9.9)0
(9,9(X))
13.114
(13.114)
20.629
{20.629>
7.980
24.512
(32.492)
110.774 (110.774)
27,012
7.852
(15.179)
(7,852)
11.833
850,OLKI
(17.IXK))
334.348 {342.393)
833.000
857,980
849.935

Cancer Lifeline
Company Limited by Guarantse
Notes to the Financial Ststements (continuEd)
Yéar ended 31 March 2025
23. Analysis of charitable funds {conJnyedJ
At
1 Apr 2023
PrKJr year
At
InccThe Expenditure Transfers adju5tment5 31 Mar 2024
Restricted Funds
- operating fund
Restricted -
Property Fund
DFC
INeighbouthood
Renewal)
National Lottery
Community Fund
{Pecyle in
Communities)
HSC {Public
He8￿h Agency)
BHSCT {Careffs
support seNice)
BHSCT (Primary
care talking
therapies)
Belfast Cty
Council {Rev8nue
Grant)
CFNI Ithr¢yJgh
DOH Carerfs
gTant)
CFNI (through
DOH Cancer
Charity Suppc
Fund)
National L￿ry
Conmunty Fund
{Domiant
Accounts)
PHA
5,108
(5.108)
161.996
(161.996)
8.830
77.948
(86.778)
14,610
50.254
{64.864}
93.520
{93.$20)
11.124
(11,124)
3.266
{3.2661
49.981
{49.981)
6.898
(6.898)
66.667
(58,687)
7,980
26,537
{30.856)
4.319
Accounts
CFNI
Belfast Cty
Counal - Property
850.OLKI 850.000
1SKI.544
386.195
(405.9741 (162.785}
850,000 857,980

Cancer Lifeline
Company Limited by Guarantee
Notes to the Financial Statsments
Year ended 31 March 2025
24. Anatysis of net assets between funds
Unrestricted
Funds
Restricted Tolal Funds
FurKIs
2025
Tangible fixed assets
Current assets
Creditors less than 1 year
Net assets
201.(64
295.09)
{9,076)
487,078
833.0(JJ
23.115
(6.1801
849.935
1.034.
318,205
{15.2561
1,337,013
Unrestricted
Funds
Restrict&J Tdal Funds
Funds
2024
Tangible fixed assets
Current assets
C￿drtOrS less than 1 year
Net assets
1,051,C64
345.158
137.198)
1.359,024
1.051.064
377,650
{61,710}
1,367.004
32,492
124.5121
7.980

Cancer Lifeline
Company Limited by Guarantee
Notes to the Financial Statements Iconlinuoo)
Year ended 31 Illarch 2025
25. Taxatlon
The Company is a ￿gISter￿j charity, as such is entilled to tax exemption5 on in¢ome and
profrts in fvrtherance cl the charity's wimary d)jectives.
Related parties
There were no ￿lated parties in the year.
27. Prior year adjustments
In preparing the 31 March 2025 accounts, it was noted that deeds of the propety of 42 Alliance
Avenue were transferred lo Cancer Lifeline in the 23r24 year. The propety funding of£850,000
which had not been re¢ognised in the prior financial statements. This ha$ been included as a
prior period adjustment and comparative anYJunts ha¥e been ieststed.
28. Analysis of changes In net debt
At
At 1 Apr 2024 Cash flows 31 Pljar 2025
Cash at bank and in hand
Bank i)verdraft5
372,207
(25.529)
346,678
(59.3851
22.983
312,822
{2,5461
310,276
(36.402)
29. Contingencles
A contingent lia￿lty exists lo repay grants and Trust rrnnies received should certain conditKsns
not be fulfilled by the charity. In the cyinion of the Trustees. the te￿5 of the Letters of Offers
have been. or will be. complied wrf(h and no liability is expected.
Can￿r Lifeline were transferred title deeds of the property 42 Aliance Avenue from Belfast Cty
Council. There is a 10 year clause induded wtthin this transfer of deeds where the CounGil would
be entitled to funds rf the property was disposed off
30. Ethlcal standards
In common wth many other businesses of our size and naure we use our auditors to ptepare
and submit retums to the tax authorttres and assist with the preparatton of the financrdl
statements.